You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健之佳(605266.SH):絕大多數門店的“一退兩抗”藥品恢復銷售
格隆匯 09-19 16:59

格隆匯9月19日丨健之佳(605266.SH)公佈,目前,疫情防控得到進一步的管控,疫情影響地區逐步解封,絕大多數門店的“一退兩抗”藥品恢復銷售,具體進展如下:

(1)雲南地區:為做好昆明市常態化疫情防控工作,滿足羣眾用藥需求,從9月18日起,昆明市主城區及周邊縣藥店恢復銷售退熱、抗病毒、抗生素、感冒、咳嗽、腹瀉等“一退兩抗”藥品恢復銷售。除昆明地區外,部分區域因疫情影響,存在少量門店“一退兩抗”藥品尚未恢復銷售或閉店的情況。

(2)省外地區:四川地區對於無社會面新增病例的區域,逐步有序恢復正常生產生活秩序,公司暫停營業門店根據各區域的政策要求陸續恢復經營,在經營過程中執行“一掃一測三查驗”(掃場所碼,測體温,查驗健康碼、48小時內核酸檢測陰性證明、行程卡)等零售藥店常態化防控措施。

目前疫情仍在持續,面對不確定性顯著上升的客觀環境,公司嚴控風險,把握穩字當頭、穩中求進的原則,日常經營活動整體保持正常,內部經營有序開展。同時公司將積極配合防疫政策的落實,加強防控確保員工及顧客的安全;穩定職工隊伍;努力組織貨源保障供應穩定,提升全渠道專業化服務能力,確保顧客中西成藥、增強抵抗力、預防、保健等用藥需求得到保障。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account